GleamWall
中文EN

ALGN ALIGN TECHNOLOGY INC

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1097149 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.4%
TTM net income YoY30.0%
TTM EPS YoY32.9%
Revenue 3-yr CAGR3.0%
Net income 3-yr CAGR10.7%

Margins

Gross margin69.1%
Operating margin14.9%
Net margin11.8%
FCF margin14.5%
EBITDA margin20.6%

Returns

ROE11.9%
ROA7.7%
ROIC (approx.)15.5%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets34.0%
Debt / equity0.00x
Current ratio1.42x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.52x
Accruals ratio-4.0%
Payout ratio—
Capex / revenue3.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.01B$1.06B$1.04B$1.05B$995.69M$1.01B$979.26M$995.22M
Cost of revenue$317.29M$298.76M$303.50M$363.97M$356.49M$304.33M$299.15M$298.28M
Gross profit$697.47M$757.43M$736.59M$683.59M$639.20M$708.12M$680.11M$696.94M
R&D expense$93.87M$102.03M$98.66M$83.04M$93.28M$96.40M$97.20M$94.88M
SG&A expense$410.55M$462.67M$465.34M$441.68M$417.80M$448.69M$447.63M$424.97M
Operating income$169.16M$154.01M$141.96M$155.32M$96.30M$163.03M$131.10M$144.15M
Pretax income$170.07M$148.69M$148.89M$176.59M$94.73M$173.52M$140.44M$140.78M
Income tax$35.03M$40.40M$36.12M$40.84M$37.98M$48.91M$47.21M$36.97M
Net income$135.04M$108.29M$112.77M$135.76M$56.75M$124.61M$93.23M$103.81M
EBITDA$208.61M$194.14M$198.50M$257.32M$152.01M$203.61M$170.25M$182.28M
EPS (basic)1.901.511.58—0.781.721.27—
EPS (diluted)1.901.511.57—0.781.721.27—
Weighted avg. shares (diluted)71.02M71.52M71.61M—72.42M72.59M73.61M—
Balance sheet
Cash & equivalents$1.14B$1.10B$1.06B$1.09B$1.01B$902.34M$874.07M$1.04B
Short-term investments———————$0
Receivables$1.16B$1.15B$1.13B$1.10B$1.10B$1.12B$1.06B$995.68M
Inventory$224.65M$212.24M$214.94M$226.34M$228.16M$243.75M$246.57M$254.29M
Current assets$2.73B$2.66B$2.66B$2.62B$2.53B$2.45B$2.40B$2.49B
PP&E, net$1.13B$1.11B$1.11B$1.13B$1.18B$1.26B$1.26B$1.27B
Goodwill$495.28M$497.30M$503.04M$491.83M$491.52M$491.07M$457.61M$442.63M
Intangibles$90.62M$94.93M$100.82M$93.93M$98.72M$103.48M$102.75M$103.49M
Total assets$6.52B$6.42B$6.31B$6.23B$6.23B$6.22B$6.10B$6.21B
Current liabilities$1.91B$1.91B$1.91B$1.92B$1.97B$2.00B$1.99B$2.04B
Total liabilities$2.22B$2.19B$2.16B$2.18B$2.28B$2.31B$2.31B$2.36B
Shareholders' equity$4.31B$4.23B$4.15B$4.05B$3.96B$3.91B$3.79B$3.85B
Shares outstanding70.69M71.25M71.62M71.36M72.04M72.49M73.06M73.85M
Cash flow statement
Operating cash flow$182.92M$192.76M$151.04M$223.18M$188.72M$128.65M$52.68M$286.08M
Capital expenditure$45.03M$35.66M$30.79M$35.92M$19.76M$21.48M$25.29M$22.96M
Free cash flow$137.89M$157.09M$120.26M$187.26M$168.96M$107.17M$27.39M$263.12M
Investing cash flow-$47.06M-$82.16M-$131.58M-$35.92M-$19.76M-$31.48M-$25.29M-$53.92M
Financing cash flow-$94.92M-$67.45M-$48.13M-$97.41M-$64.12M-$96.30M-$206.76M-$203.02M
Depreciation & amortization$39.45M$40.13M$56.55M$102.00M$55.72M$40.58M$39.15M$38.13M
Stock-based compensation$39.03M$45.56M$40.92M$44.29M$48.38M$48.21M$45.00M$38.85M
Share buybacks$103.06M$66.93M$31.20M$97.25M$71.56M$96.05M$201.09M$202.87M

Free plan shows the latest 8 periods; Pro shows all 71 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.